INT280447

Context Info Confidence 0.00 First Reported 2009 Last Reported 2009 Negated 0 Speculated 0 Reported most in Abstract Documents 1 Total Number 1 Disease Relevance 0.75 Pain Relevance 0.69

cytosol (MOCS1) small molecule metabolic process (MOCS1) nucleus (MOCS1)

MOCS1 (Homo sapiens)

Pain Link Frequency Relevance Heat pregabalin 124 96.16 Calcium channel 3 93.92 Pain 6 77.84 diabetic neuropathy 6 77.20 postherpetic neuralgia 3 75.20 Fibrositis 4 72.24 antiepileptic Drug 12 5.00 withdrawal 4 5.00 Pain score 3 5.00 anticonvulsant 2 5.00

Disease Link Frequency Relevance Heat Convulsion 32 89.60 Partial Seizures 18 88.52 Diabetic Neuropathy 3 77.20 Post Operative Pain 3 75.20 Pain 7 73.04 Sleep Disorders 9 72.24 Anxiety Disorder 8 66.80 Dizziness 7 54.32 Ataxia 6 53.44 Diplopia 5 51.60

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Its pharmacokinetic advantages include rapid and almost complete absorption, lack of protein binding, linear kinetics, absence of enzyme induction, and absence of interactions with other drugs.

Negative_regulation (absence) of Positive_regulation (induction) of enzyme

1) Confidence 0.00 Published 2009 Journal Neuropsychiatric Disease and Treatment Section Abstract Doc Link PMC2732007 Disease Relevance 0.75 Pain Relevance 0.69

General Comments

This test has worked.